About Firm News
In the News
John Shakow and David Farber comment on the limitations of rebates and cost savings for health plans and patients under new Medicare drug programs
January 19, 2026
| Managed Healthcare Executive
Featured Lawyers:
Person John Shakow
John D. Shakow
Partner
Person David Farber
David J. Farber
Partner

Go to the article

Related Capabilities
Life Sciences & Healthcare Special Matters & Government Investigations FDA & Life Sciences Government Advocacy & Public Policy
Featured Lawyers
Person John Shakow
John D. Shakow
Partner
Government Matters & Regulation
Person David Farber
David J. Farber
Partner
Government Matters & Regulation